Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Properly monitored hormone therapy can improve life quality, but misuse can cause serious health issues.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Hirsutism is excessive male-pattern hair growth mainly caused by ovarian hormones, and severe cases may require costly treatment with side effects.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Topical eflornithine effectively reduces facial hair in women and improves quality of life.

Finasteride safely reduces excessive hair growth in women.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Hirsutism in women is mostly due to PCOS and can be managed with oral contraceptives and hair removal methods.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.